Humacyte, Inc. (HUMA)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$0.5573−$0.0114 (−2.00%) on the dayAs of the close; data may be delayed.
HUMA price, last 12 months
Key stats
- Previous close
- $0.5687
- Open
- $0.5600
- Day range
- $0.5500 – $0.5713
- 52-week range
- $0.5261 – $2.55
- Volume
- 2.6M
- Avg volume (20 days)
- 4.7M
- Market cap
- $154.8M
Performance
1W−4.8%
1M−18.2%
3M−21.4%
6M−28.4%
YTD−42.0%
1Y−66.8%
vs S&P 500, 1Y−83.6 pts
Technicals and fundamentals
About Humacyte, Inc.
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $154.8M